Evolutionary Dissection Of MtDNA Hg H: A Susceptibility Factor For ...

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Mitochondrial DNA (mtDNA) haplogroup (hg) H has been reported as a susceptibility factor for hypertrophic cardiomyopathy (HCM). This was established in genetic association studies, however, the SNP or SNP's that are associated with the increased risk have not been identified. Hg H is the most frequent European mtDNA hg with greater than 80 subhaplogroups (subhgs) each defined by specific SNPs. We tested the hypothesis that the distribution of H subhgs might differ between HCM patients and controls. The subhg H distribution in 55 HCM index cases was compared to that of two Danish mtDNA hg H control groups (n = 170 and n = 908, respectively). In the HCM group, H and 12 different H subhgs were found. All these, except subhgs H73, were also found in both control groups. The HCM group was also characterized by a higher proportion of H3 compared to H2. In the HCM group the H3/H2 proportion was 1.7, whereas it was 0.45 and 0.54 in the control groups. This tendency was replicated in an independent group of Hg H HCM index cases (n = 39) from Queensland, Australia, where the H3/H2 ratio was 1.5. In conclusion, the H subhgs distribution differs between HCM cases and controls, but the difference is subtle, and the understanding of the pathogenic significance is hampered by the lack of functional studies on the subhgs of H.

Keywords: Haplogroup and MutPred; Hypertrophic cardiomyopathy; mtDNA.

PubMed Disclaimer

Similar articles

• Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population. Hagen CM, Aidt FH, Hedley PL, Jensen MK, Havndrup O, Kanters JK, Moolman-Smook JC, Larsen SO, Bundgaard H, Christiansen M. Hagen CM, et al. PLoS One. 2013 Aug 5;8(8):e71904. doi: 10.1371/journal.pone.0071904. Print 2013. PLoS One. 2013. PMID: 23940792 Free PMC article.
• Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy. Hagen CM, Aidt FH, Havndrup O, Hedley PL, Jensen MK, Kanters JK, Pham TT, Bundgaard H, Christiansen M. Hagen CM, et al. PLoS One. 2015 Apr 29;10(4):e0124540. doi: 10.1371/journal.pone.0124540. eCollection 2015. PLoS One. 2015. PMID: 25923817 Free PMC article.
• Mitochondrial DNA variations associated with hypertrophic cardiomyopathy. Govindaraj P, Khan NA, Rani B, Rani DS, Selvaraj P, Jyothi V, Bahl A, Narasimhan C, Rakshak D, Premkumar K, Khullar M, Thangaraj K. Govindaraj P, et al. Mitochondrion. 2014 May;16:65-72. doi: 10.1016/j.mito.2013.10.006. Epub 2013 Nov 9. Mitochondrion. 2014. PMID: 24215792
• [Advances in the molecular pathogenesis of hypertrophic cardiomyopathy]. Song YR, Liu Z, Gu SL, Qian LJ, Yan QF. Song YR, et al. Yi Chuan. 2011 Jun;33(6):549-57. doi: 10.3724/sp.j.1005.2011.00549. Yi Chuan. 2011. PMID: 21684859 Review. Chinese.
• Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B. Sedaghat-Hamedani F, et al. Clin Res Cardiol. 2018 Jan;107(1):30-41. doi: 10.1007/s00392-017-1155-5. Epub 2017 Aug 24. Clin Res Cardiol. 2018. PMID: 28840316 Review.

See all similar articles

Cited by

• Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy. Kargaran PK, Evans JM, Bodbin SE, Smith JGW, Nelson TJ, Denning C, Mosqueira D. Kargaran PK, et al. J Clin Med. 2020 Jul 23;9(8):2349. doi: 10.3390/jcm9082349. J Clin Med. 2020. PMID: 32718021 Free PMC article.

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Adolescent Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adult Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Australia Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Cardiomyopathy, Hypertrophic / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Case-Control Studies Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Child Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• DNA, Mitochondrial / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Denmark Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Female Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Genetic Predisposition to Disease Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Haplotypes Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Middle Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mitochondria / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Polymorphism, Single Nucleotide* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Young Adult Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• DNA, Mitochondrial Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Related information

• MedGen

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • figshare - Data